The purpose of this study is to compare the effectiveness of two anti-craving medications,
naltrexone versus acamprosate, in the treatment of alcohol dependence.
Phase:
Phase 4
Details
Lead Sponsor:
University of Sydney
Collaborators:
National Health and Medical Research Council, Australia South Eastern Area Health Service Sydney South West Area Health Service Wentworth Area Health Services